Codexis
Codexis is an industrial biotechnology company headquartered in Redwood City, California, founded in 2002. It develops and sells protein catalysts and biocatalytic solutions for pharmaceutical and chemical manufacturing. Using its proprietary CodeEvolver directed‑evolution platform, Codexis engineers enzymes that enable scale‑up and optimization of processes from research to production. Products include protein catalysts, biocatalyst panels, kits, and services such as screening and engineering. The platform also supports discovery of biotherapeutic drug candidates, molecular‑biology enzymes, and in‑vitro diagnostics, and it is developing an ECO Synthesis platform for RNAi therapeutics manufacturing. More than 50 pharmaceutical firms use Codexis solutions.
Top Stages
3 past transactions
seqWell
Series C in 2022
seqWell is a biotechnology company focused on sequencing library preparation and related laboratory services. It provides library preparation kits, materials for nucleic acid purification, sequencing services, data processing, and customized bioinformatics support. Its technology platform enables simple, scalable multiplexing of hundreds to thousands of samples without time- and cost-intensive normalization, improving consistency and reducing downstream handling. The company markets its products through distributors in the United States and across several countries, and sells online. Founded in 2014, seqWell is headquartered in Beverly, Massachusetts.
Molecular Assemblies
Series B in 2022
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
Molecular Assemblies
Series A in 2021
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.